Market Place
Sourcing Support
Neogenomics` Pantracer Lbx Receives Medicare Coverage, Expanding
16 Mar 2026 //
BUSSINESSWIRE
NeoGenomics Launches RaDaR ST for Solid Tumors Type
25 Feb 2026 //
PHARMIWEB
NeoGenomics To Participate In Upcoming Investor Conferences
18 Feb 2026 //
BUSINESSWIRE
NeoGenomics Reports Fourth Quarter And Full Year 2025 Results
17 Feb 2026 //
PHARMIWEB
NeoGenomics Launches PanTracer Pro For Solid Tumor Therapy
12 Feb 2026 //
PHARMIWEB
NeoGenomics To Release Q4 And Full Year 2025 Financial Results
27 Jan 2026 //
BUSINESSWIRE
NeoGenomics Announces Preliminary Q4 and Full-Year 2025 Revenue
12 Jan 2026 //
PHARMIWEB
Neogenomics To Attend J.P. Morgan Healthcare Conference
05 Jan 2026 //
BUSINESSWIRE
Neogenomics Appoints Industry Veteran Jack Kenny To Board
30 Dec 2025 //
BUSINESSWIRE
Natera Withdraws Appeal in NeoGenomics RaDaR Patent Litigation
15 Dec 2025 //
BUSINESSWIRE
Neogenomics To Present New Ctdna Research At SABCS 2025
10 Dec 2025 //
BUSINESSWIRE
NeoGenomics Presents CGP Study on Myeloid Malignancies at ASH
08 Dec 2025 //
PHARMIWEB
Neogenomics To Participate In Upcoming Investor Conferences
06 Nov 2025 //
BUSINESSWIRE
NeoGenomics to Present RaDaR ST MRD Study at ISLB 2025
30 Oct 2025 //
BUSINESSWIRE
Neogenomics Reports Third Quarter 2025 Results
28 Oct 2025 //
BUSINESSWIRE
Neogenomics To Highlight Radar ST MRD Assay At ESMO Congress 2025
14 Oct 2025 //
PHARMIWEB
Neogenomics To Release Q3 2025 Financial Results On October 28
07 Oct 2025 //
PHARMIWEB
Court Rules for NeoGenomics in Patent Lawsuit Against Natera
29 Aug 2025 //
PHARMAWEB
NeoGenomics Introduces PanTracer LBx for Enhanced Genomic Profile
30 Jul 2025 //
BUSINESSWIRE
NeoGenomics Announces Q2 2025 Results
29 Jul 2025 //
BUSINESSWIRE
NeoGenomics to Report Q2 2025 Financial Results on July 29
01 Jul 2025 //
BUSINESSWIRE
NeoGenomics Launches PanTracer Tissue for Cancer Care
30 Jun 2025 //
BUSINESSWIRE
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
24 Jun 2025 //
BUSINESSWIRE
NeoGenomics Introduces PanTracer Genomic Tests at ASCO 2025
28 May 2025 //
BUSINESSWIRE
NeoGenomics Launches c-MET CDx Assay for Advanced Lung Cancer
22 May 2025 //
BUSINESSWIRE
NeoGenomics to Participate in Upcoming June Investor Conferences
20 May 2025 //
BUSINESSWIRE
NeoGenomics Pays Off 1.25% Convertible Senior Notes
01 May 2025 //
BUSINESSWIRE
NeoGenomics Reports First Quarter 2025 Results
29 Apr 2025 //
BUSINESSWIRE
NeoGenomics to Present PanTracer LBx Study at AACR Meeting
22 Apr 2025 //
BUSINESSWIRE
NeoGenomics to Report Q1 2025 Financial Results on April 29
08 Apr 2025 //
BUSINESSWIRE
NeoGenomics Completes Acquisition of Pathline
07 Apr 2025 //
BUSINESSWIRE
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
01 Apr 2025 //
BUSINESSWIRE
NeoGenomics Appoints Warren Stone As President, COO
18 Mar 2025 //
BUSINESSWIRE
NeoGenomics Expands Oncology Testing With Pathline Acquisition
10 Mar 2025 //
BUSINESSWIRE
NeoGenomics to Participate in Upcoming Investor Conferences
24 Feb 2025 //
BUSINESSWIRE
NeoGenomics to Report Q4 & Full Year Financial Results on Feb 18
29 Jan 2025 //
BUSINESSWIRE
Adaptive Bio & NeoGenomics Expand Cancer Disease Monitoring Access
14 Jan 2025 //
GLOBENEWSWIRE
NeoGenomics to Present Research on Hematologic Malignancies at ASH
09 Dec 2024 //
BUSINESSWIRE
NeoGenomics at Piper Sandler 36th Healthcare Conference
08 Nov 2024 //
BUSINESSWIRE
NeoGenomics Reports Q32024 Results
05 Nov 2024 //
BUSINESSWIRE
NeoGenomics to Report Q3 2024 Financial Results on Nov. 5, 2024
15 Oct 2024 //
BUSINESSWIRE
NeoGenomics Launches AML Express For Rapid Genetic Profiling
08 Oct 2024 //
BUSINESSWIRE
NeoGenomics Announces New RaDaR Technology Litigation Resolved
23 Sep 2024 //
BUSINESSWIRE
NeoGenomics To Present New Cancer Diagnostics Data At ESMO 2024
11 Sep 2024 //
BUSINESSWIRE
NeoGenomics To Participate In Morgan Stanley Healthcare Conference
29 Aug 2024 //
BUSINESSWIRE
NeoGenomics Reports Second Quarter 2024 Results
29 Jul 2024 //
BUSINESSWIRE
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
09 Jul 2024 //
BUSINESSWIRE
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
13 Jun 2024 //
BUSINESSWIRE
NeoGenomics: Lung Solution, Hematopathology Services Insights At ASCO
28 May 2024 //
BUSINESSWIRE
NeoGenomics Reports First Quarter 2024 Results
30 Apr 2024 //
BUSINESSWIRE
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at Meeting
27 Mar 2024 //
BUSINESSWIRE
NeoGenomics Releases Inaugural Environmental, Social, and Governance Report
20 Mar 2024 //
BUSINESSWIRE
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
01 Mar 2024 //
BUSINESSWIRE
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
20 Feb 2024 //
BUSINESSWIRE
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
01 Feb 2024 //
BUSINESSWIRE
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results
30 Jan 2024 //
BUSINESSWIRE
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
BUSINESSWIRE
NeoGenomics to Appeal Ruling
28 Dec 2023 //
ACCESSWIRE
NeoGenomics to Participate at Piper Sandler 35th Annual Healthcare Conference
14 Nov 2023 //
ACCESSWIRE
NeoGenomics Reports Third Quarter 2023 Results
06 Nov 2023 //
ACCESSWIRE
